<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02078336</url>
  </required_header>
  <id_info>
    <org_study_id>S55859</org_study_id>
    <secondary_id>2013-003991-11</secondary_id>
    <nct_id>NCT02078336</nct_id>
  </id_info>
  <brief_title>Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability</brief_title>
  <acronym>OptiSeDent</acronym>
  <official_title>Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to compare procedural sedation protocols, specifically applied for the
      delivery of regular dental care in persons with a mental disability.

      The primary objectives are:

        -  To assess the level of cooperation during regular dental care using different procedural
           sedation protocols

        -  To assess patient safety during regular dental care using different sedation protocols

        -  To assess patient comfort and possible side-effects after regular dental care using
           different sedation protocols
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of cooperation of patient when receiving regular dental care</measure>
    <time_frame>Participants will be followed for the duration of the dental treatment, an expected average of 30 minutes.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recording of vital parameters during regular dental care delivery</measure>
    <time_frame>24 hrs</time_frame>
    <description>The measure is a composite of
recording of blood pressure
recording of pulse
recording of oxygen saturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of patient comfort and possible side-effects after dental treatment session</measure>
    <time_frame>24 hrs</time_frame>
    <description>The measure of patient comfort and possible side-effects after dental treatment session is a composite of
changes in appetite
changes in toilet behavior
changes in level of consciousness
changes in level of concentration
changes in pattern of epileptic insults
changes in mood
changes in sleeping pattern
changes in level of motor skills</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Dental Care for Disabled</condition>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Midazolam Mylan 5 mg/ml solution for injection 15mg Oral use Single dose 45 minutes before dental treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lorazepam / Valium+Akineton+Dehydrobenzperidol+Atropine sulfat</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lorazepam Mylan 2,5 mg tabletten 2.5mg Oral use Single dose 45 minutes before dental treatment
OR
Valium 10 mg/2 ml solution for injection 10mg Intramuscular use Single dose 45 minutes before dental treatment
+ Akineton 5 mg/ml solution for injection 5mg Intramuscular use Single dose 45 minutes before dental treatment
+ Dehydrobenzperidol 5 mg/2 ml solution for injection 0,000125 ml/cm2 Intramuscular use Single dose 45 minutes before dental treatment
+ Atropine sulfate Sterop 0,25mg/1ml solution for injection 0,25mg Intramuscular use Single dose 45 minutes before dental treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam Mylan</intervention_name>
    <arm_group_label>Midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lorazepam Mylan</intervention_name>
    <arm_group_label>Lorazepam / Valium+Akineton+Dehydrobenzperidol+Atropine sulfat</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Valium + Akineton + Dehydrobenzperidol + Atropine sulfate</intervention_name>
    <arm_group_label>Lorazepam / Valium+Akineton+Dehydrobenzperidol+Atropine sulfat</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Minimum age 18yrs

          -  Patient resides at least 6 months in nursing home &quot;het Gielsbos&quot;.

          -  Patient always gets a sedative protocol to make dental care delivery possible.

          -  Informed consent was obtained from parent/guardian

          -  No medical contra-indication for any of tested sedative protocols

        Exclusion Criteria:

          -  Age under 18yrs

          -  The patient is no resident of the nursing home &quot;het Gielsbos&quot; or lives there for less
             than 6 months.

          -  No need for medicinal support during dental treatment

          -  No informed consent was obtained by parents or the guardian of the patient.

          -  Medical contra-indication for 1 of the sedative protocols
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique Declerck</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholieke Universiteit Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dominique Declerck</last_name>
    <email>dominique.declerck@med.kuleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ine Opsomer</last_name>
    <email>ine.opsomer@uzleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Katholieke Universiteit Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique Declerck</last_name>
      <email>dominique.declerck@med.kuleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Ine Opsomer</last_name>
      <email>ine.opsomer@uzleuven.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2014</study_first_submitted>
  <study_first_submitted_qc>February 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2014</study_first_posted>
  <last_update_submitted>February 28, 2014</last_update_submitted>
  <last_update_submitted_qc>February 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Diazepam</mesh_term>
    <mesh_term>Droperidol</mesh_term>
    <mesh_term>Lorazepam</mesh_term>
    <mesh_term>Biperiden</mesh_term>
    <mesh_term>Biperiden lactate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

